Angioplastie coronaire

Jeudi 12 Janvier 2023   08:30-09:30   Salle 352 A
JESFC 2023   |   Communication orale
08:30 • Philippe Garot
2 years outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The Biofreedom France Study
Voir la présentation
08:37 • Quentin Landolff
Five-year clinical outcomes using the bioresorbable vascular scaffold: Insights from the FRANCE ABSORB registry
Voir la présentation
08:44 • Eric Durand
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with indication of anticoagulation treated by PCI: a retrospective analysis of the FRANCE PCI registry
Voir la présentation
08:51 • Antoine Léquipar
Description and 30-day prognosis of same-day discharge after elective percutaneous coronary intervention in elderly patients: a single-centre registry
Voir la présentation
08:58 • Afef Ben Halima
Study of cardiovascular comorbidities in ambulatory patients with COVID-19 and their impact on prognosis in the TASC GP study
Voir la présentation
09:05 • Luc Maillard
How short can we reduce DAPT for HBR patients ? MAPT after COBRA PzF™ NanoCoated Coronary Stent implantation. 200 patients at 1 year
Voir la présentation
09:12 • Aimen Boughariou
Descriptive and prognostic study at 5 years of percutaneous coronary intervention by long active stents ≥ 40 mm